The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165.
Southern Copper Corp
SCCO · the NYSE · USD · Market cap $163.9B · 16,617 employees
Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Mexico, the United States, Peru, Brazil, Chile, and Other American countries.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 23:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Southern Copper Corp holds its Markup at $194.14. Consolidating, no directional conviction, held for 9 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 9 days |
| Price at the screen | $194.14 |
| Valuation | 29.19 trailing · 26.68 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.15 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 34.67% | Below 33% | Interest-bearing debt is 34.7% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 2.83% | Below 33% | Cash held in interest-bearing accounts and securities is 2.8% of assets, under the one-third limit. | Pass |
| Receivables | 29.59% | Below 49% | Money owed to the company is 29.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.49% | Below 5% | Only 1.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. The price runs 41.9% above the base estimate.
Third-party analyst targets: 17 covering, consensus Underperform. The average target sits −16% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCopper Cycle Risks Cloud SCCO's Shine
Imagine a copper mining machine humming in the Andes, its production echoing Southern Copper Corp's revenue growth of 41%. The glittering metal it produces makes up the veins of our electronic world, but the business cycles of copper are as volatile as the Andean weather. Why it stands out, or rather, why we pass: despite robust revenue and profit margins, SCCO's cyclical nature paired with a high forward P/E of 30x and our fair value of $111.68 (-48% margin of safety) suggests we're potentially at the peak of earnings, which is a classic cyclical value trap.
The market consensus, echoed by 17 analysts with an underperform rating and a median target of $163, aligns with our caution. Coupled with a narrow moat and a debt ratio that fails our ethical screen, SCCO, unfortunately, does not meet our standards. Risk sits with the industry's cyclical nature, the high P/E indicating peak earnings, and the ethical failings that signal potential vulnerabilities.
Analysis, not advice.
| Forward P/E | 26.7xcheap for a company growing this fast |
| Trailing P/E | 29.2xa premium valuation |
| EPS, trailing | 6.65 |
| EPS, forward | 7.28 |
| Revenue growth | +40.6%growing very fast |
| Profit margin | 35.9%highly profitable on every dollar of sales |
| Return on equity | 49.9%an exceptional return on shareholder capital |
| FCF yield | 3.05% |
| Dividend yield | 211.00% |
| Debt to equity | 0.68moderate, manageable leverage |
| Current ratio | 5.06comfortably covers its short-term bills |
| Beta | 1.15moves a little more than the market |
| Short interest, float | 0.11% |
| 52-week range | 97.99 - 220.78 |
| Moat | NARROW |
| Market cap | $163.9B |
| Employees | 16,617 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSCCO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 9.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 83%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (16 analysts) rates it underperform, with a mean price target of $165.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Will FCX's Margins Hold Up as Copper Production Costs Rise? Zacks · 3d ago
- Why Did Freeport-McMoRan Stock Drop On Doubts Over A Tariff It Would Gain From? Trefis · 7d ago
- FCX's Shares Up 20% in 6 Months: What Should Investors Do Now? Zacks · 7d ago
- Southern Copper (SCCO) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · 8d ago
- Copper Stocks Tumble as Tariff Doubt Reverses Record Rally: Freeport-McMoRan Sinks 8%, Teck Resources and Southern Copper Drop 7% 24/7 Wall St. · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $182.44 | -8.1% | $0.99 | $925 | -7.5% |
| 2 months | $189.66 | -11.6% | $0.99 | $889 | -11.1% |
| 3 months | $177.84 | -5.7% | $0.99 | $948 | -5.2% |
| 6 months | $143.56 | +16.8% | $1.97 | $1,182 | +18.2% |
| 1 year | $91.88 | +82.5% | $3.62 | $1,864 | +86.4% |
| 2 years | $99.06 | +69.3% | $6.19 | $1,755 | +75.5% |
| 3 years | $61.77 | +171.5% | $8.83 | $2,858 | +185.8% |
| 5 years | $51.48 | +225.7% | $15.83 | $3,565 | +256.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SCCO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.